MIRA INFORM REPORT

 

 

Report Date :

01.11.2012

 

IDENTIFICATION DETAILS

 

Name :

BAROQUE PHARMACEUTICALS PRIVATE LIMITED

 

 

Registered Office :

At- Sokhada , Khambhat, Taluka Khambhat, District Anand – 388620, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

23.11.1993

 

 

Com. Reg. No.:

04-020695

 

 

Capital Investment / Paid-up Capital :

Rs.4.625 Millions

 

 

CIN No.:

[Company Identification No.]

U24230GJ1993PTC020695

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

AHMB00048G

 

 

PAN No.:

[Permanent Account No.]

AAACB6277H

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Marketer of Pharmaceuticals Formulations.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (47)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 150000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. There appears some dip in the sales turnover and profits earned during 2011.

 

However, trade relations are reported as decent. Business is active. Payments are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and conditions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

LOCATIONS

 

Registered Office / Factory :

At- Sokhada , Khambhat, Taluka Khambhat, District Anand – 388620, Gujarat, India

Tel. No.:

91-2698-222449 / 226286

Fax No.:

91-2698-223483

E-Mail :

mail@baroquepharma.com

baroque@icenet.com

bppl@baroquepharma.com

baroque@sancharnet.in  

Website :

http://www.baroquepharma.com

 

 

DIRECTORS

 

As on 30.09.2011

 

Name :

Mr. Jayantibhai Dhulabhai Patel

Designation :

Director

Address :

97, Nityanand Society, Ambakhan Road, Khambhat, Anand – 388620, Gujarat, India

Date of Birth/Age :

15.07.1955

Date of Appointment :

01.04.1996

DIN No.:

00336835

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24230GJ1993PTC020695

BAROQUE PHARMACEUTICALS PRIVATE LIMITED

Managing director

27/04/2012

01/04/1996

Active

NO

2

U24230GJ1998PTC034955

REPLICA REMEDIES PRIVATE LIMITED

Director

15/04/2005

15/04/2005

Active

NO

3

U24239GJ2010PTC060152

VIDACARE PHARMACEUTICALS PRIVATE LIMITED

Director

05/04/2010

05/04/2010

Active

NO

 

 

Name :

Mr. Pragnesh Jayantibhai Patel

Designation :

Director

Address :

97, Nityanand Society, Ambakhan Road, Khambhat, Anand – 388620, Gujarat, India

Date of Birth/Age :

02.08.1984

Date of Appointment :

01.05.2003

DIN No.:

00336790

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24230GJ1993PTC020695

BAROQUE PHARMACEUTICALS PRIVATE LIMITED

Director

01/05/2003

01/05/2003

Active

NO

2

U24230GJ1998PTC034955

REPLICA REMEDIES PRIVATE LIMITED

Director

01/04/2005

01/04/2005

Active

NO

 

 

Name :

Dr. Jignesh Mayurbhai Patel

Designation :

Director

Address :

Shivam Hospital, Khambhat, Anand – 388620, Gujarat, India

Date of Birth/Age :

26.04.1976

Date of Appointment :

01.04.2008

DIN No.:

02194627

 

Other Directorship:

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24230GJ1993PTC020695

BAROQUE PHARMACEUTICALS PRIVATE LIMITED

Whole-time director

27/04/2012

01/04/2008

Active

NO

2

U24239GJ2010PTC060152

VIDACARE PHARMACEUTICALS PRIVATE LIMITED

Director

05/04/2010

05/04/2010

Active

NO

 

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2011

 

Names of Shareholders

 

No. of Shares

 

 

 

Jayantibhai Dhulabhai Patel

 

25270

Manjulaben Jayantibhai Patel

 

4450

Pragnesh Jayantibhai Patel

 

13420

Jayantibhai Dhulabhai Patel Jointly with  Manjulanen Jayantibhai Patel

 

2040

Amita Jayantibhai Patel

 

500

Ashokbhai Purshottambhai Patel Jointly with Jayeshbhai Rayjibhai Patel Satishbhai Kantilal Shah

 

40

Jigneshbhai Mayurbhai Patel

 

530

Total

 

46250

 

As on 30.09.2011

 

Equity Share Break up (Percentage of Total Equity)

 

Category

Percentage

Directors or relatives of Directors

100.00

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Marketer of Pharmaceuticals Formulations.

 

 

GENERAL INFORMATION

 

No. of Employees :

Not Available

 

 

Bankers :

Bank of Baroda, Cambay Industrial Estate Branch, Kansari - 388630, Gujarat, India

 

 

Facilities :

Secured Loan

As on

31.03.2011

(Rs. in

Millions)

As on

31.03.2010

(Rs. in

Millions)

 

 

 

Bank of Baroda - Kansari Branch Term Loan A/c. - 1 A/c.No.029306000008578

(Secured against Hypothecation of stock of raw materials, packing materials, work in process and finished goods)

17.667

3.000

Bank of Baroda - Kansari Branch Term Loan A/c -2 A/c. No,02930600008715

(Secured against New project Land Building and Plant and Machinery)

4.000

0.000

Total

21.667

3.000

 

 

 

Unsecured Loan

As on

31.03.2011

(Rs. in

Millions)

As on

31.03.2010

(Rs. in

Millions)

 

 

 

From Share holders & Directors

9.233

5.480

Total

9.233

5.480

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

B C Patel and Company

Chartered Accountants

Address :

Desai Building, Mayfair Road, Anand – 388001, Gujarat, India

PAN No.:

AENPP3444E

 

 

CAPITAL STRUCTURE

 

As on 31.03.2011

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

50000

Equity Shares

Rs.100/- each

Rs.5.000 Millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

46250

Equity Shares

Rs.100/- each

Rs.4.625 Millions

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

4.625

2.275

2.275

2] Share Application Money

0.000

0.350

0.000

3] Reserves & Surplus

32.778

27.767

21.314

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

37.403

30.392

23.589

LOAN FUNDS

 

 

 

1] Secured Loans

21.667

3.000

0.000

2] Unsecured Loans

9.233

5.480

4.241

TOTAL BORROWING

30.900

8.480

4.241

DEFERRED TAX LIABILITIES

0.753

0.753

0.702

 

 

 

 

TOTAL

69.056

39.625

28.532

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

63.678

23.349

18.126

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.004

0.004

0.004

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

6.716

6.157

11.484

 

Sundry Debtors

25.237

27.038

16.845

 

Cash & Bank Balances

2.770

4.135

0.238

 

Other Current Assets

0.000

0.000

0.000

 

Loans & Advances

6.092

5.152

1.956

Total Current Assets

40.815

42.482

30.523

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

32.303

22.088

18.058

 

Other Current Liabilities

1.470

0.882

0.798

 

Provisions

2.515

3.240

1.265

Total Current Liabilities

36.288

26.210

20.121

Net Current Assets

4.527

16.272

10.402

 

 

 

 

MISCELLANEOUS EXPENSES

0.847

0.000

0.000

 

 

 

 

TOTAL

69.056

39.625

28.532

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income

NA

NA

NA

 

 

Other Income

 

 

 

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

NA

NA

NA

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

NA

NA

NA

 

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION

11.034

8.928

4.790

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION        

1.506

1.617

1.350

 

 

 

 

 

 

PROFIT BEFORE TAX

9.528

7.311

3.440

 

 

 

 

 

Less

TAX                                                     

3.076

2.300

1.164

 

 

 

 

 

 

PROFIT AFTER TAX

6.452

5.011

2.276

 

 

 

 

 

 

Earnings Per Share (Rs.)

139.50

NA

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

Return on Total Assets

(PBT/Total Assets}

(%)

9.12

11.11

7.07

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.25

0.24

0.15

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.80

1.14

1.03

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.12

1.62

1.52

 

 


 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

No

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

--

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

OPERATION:

 

The working of the company during the year remained satisfactory. During the year, total production of medicines remained decreased as compared previous year, However, the margin on sales on export sales remained satisfactory in export sales prices during the year.

 

It is expected to maintain the sale and profitability in coming years of operation.

 

BANKERS CHARGES REPORT AS PER REGISTRY

 

Corporate identity number of the company

U24230GJ1993PTC020695

Name of the company

BAROQUE PHARMACEUTICALS PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

At- Sokhada , Khambhat, Taluka Khambhat, District Anand – 388620, Gujarat, India

E-Mail id : mail@baroquepharma.com

This form is for

Creation of charge

Type of charge

Immovable property

Particular of charge holder

Bank of Baroda, Cambay Industrial Estate Branch, Kansari - 388630, Gujarat, India

E-mail Id : indcam@bankofbaroda.com

Nature of instrument creating charge

Instrument relating to deposit of title deed

Date of instrument Creating the charge

07/10/2010

Amount secured by the charge

Rs.20.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Extent and Operation of the charge

The charge shall operate as the first charge over the mortgaged properties mortgaged to the bank to secure the term loan granted by bank with interest, Cost, charges, etc.

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Open land of S.Y. No. 192/2 Paiki West Portion Admj. 4157 S.M. Sokhada, Khambhat with construction property Sr. No. 19 and property No. 19 on assessment register of Sokhada.

 

S. Y. no. 192/3 P Admj. 3000 S.M. with construction property Sr. No. 17 and property No. 17 on assessment register of Sokhada Gram Panchyat, Khambhat.

 

Open land of S.Y. No. 192/3 Admj. 3000 S.M. Sokhada, Khambhat West-North Portion.

 

Open land of S.Y. No. 202/9 P Admj. 235 S.M. Sokhada, Khambhat.

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.12

UK Pound

1

Rs.87.08

Euro

1

Rs.70.15

 

 

INFORMATION DETAILS

 

Report Prepared by :

BSN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

4

OPERATING SCALE

1~10

6

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

6

--MARGINS

-5~5

-

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

47

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.